immune system
|
• thymus contains few CD44+,CD25-,CD117++ double negative (DN1) cells and CD44+,CD25+ double negative (DN2) cells, representing 7.5% of that in a control mouse
(J:81133)
• the number of DN1 and DN2 cells is decreased
(J:91542)
• the population of DN1 cells remaining is enriched for proliferating CD117+ cells
(J:91542)
|
|
• the number of DN3 cells is increased 2 fold
|
|
• a complete block in T cell development at the double negative 3 stage is seen
|
|
• proportion of CD19+, B220+ B cells in the neonatal thymus is extremely low
|
|
• contact hypersensitivity is abolished compared to in wild-type mice
|
|
• mice show no sign of lesion development for up to 12 to 14 weeks after infection; after 20 weeks, all lesions remain small
• mice reconstituted with 1x10 7 CD4+ T cells develop smaller lesions containing 100-fold less parasites than wild-type or mutants reconstituted with 1.5x10 7 CD4+ T cells
|
digestive/alimentary system
|
• when given 10-20 mg/kg indomethacin, mice develop small nonhemorrhagic lesions in the jejunum, similar to controls in severity
|
|
• when given 10-20 mg/kg indomethacin, mice develop extensive hemorrhagic lesions of the gastric mucosa, similar to controls in severity
|
hematopoietic system
|
• thymus contains few CD44+,CD25-,CD117++ double negative (DN1) cells and CD44+,CD25+ double negative (DN2) cells, representing 7.5% of that in a control mouse
(J:81133)
• the number of DN1 and DN2 cells is decreased
(J:91542)
• the population of DN1 cells remaining is enriched for proliferating CD117+ cells
(J:91542)
|
|
• the number of DN3 cells is increased 2 fold
|
|
• a complete block in T cell development at the double negative 3 stage is seen
|
|
• proportion of CD19+, B220+ B cells in the neonatal thymus is extremely low
|


Analysis Tools